By contrast, in the apocrine breast cancer subtype- an ER negative tumor- the AR acts by binding to the same transcription factors as the ER does, mainly through FOXA1, leading to a luminal gene expression phenotype [8]. The gene discussed is AR; the disease is breast cancer.